๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity

โœ Scribed by Youichi Mizutani; Yusaku Okada; Osamu Yoshida; Manabu Fukumoto; Benjamin Bonavida

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
366 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

RESULTS. The T24 human bladder carcinoma cell line constitutively expressed the

Fas on the cell surface; however, T24 line was resistant to anti-Fas MoAb. Treatment

๐Ÿ“œ SIMILAR VOLUMES

Sensitization of immunoresistant prostat
Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: Independence of de novo protein synthesis
โœ Frost, Patrick J.; Belldegrun, Arie; Bonavida, Benjamin ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 350 KB ๐Ÿ‘ 2 views

We recently reported that drug-resistant prostate tumor cells (DU145, PC-3) are resistant to Fas-mediated killing by cytotoxic lymphocytes, and that this resistance can be overcome by treatment with subtoxic concentrations of chemotherapeutic drugs. Fas belongs to the tumor necrosis factor (TNF) fam

Drug-resistant human bladder-cancer cell
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
โœ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici

Differential sensitivity of human papill
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
โœ Adriana Aguilar-Lemarroy; Sabine Kirchhoff; Noel Whitaker; Patricio Gariglio; Ha ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 343 KB

When cervical carcinoma cells were monitored for apoptotic signals, HPV18 ุ‰ lines were found to be highly sensitive to agonistic CD95 antibodies or recombinant CD95 ligands after co-exposure with CHX (CD95 S ). In contrast, HPV16 ุ‰ cervical carcinoma cells and HPV16-immortalized non-malignant human

Treatment of the P815 murine mastocytoma
Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells
โœ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 122 KB ๐Ÿ‘ 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (

Differential expression of collateral se
Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin
โœ Philip Bedford; Sharon A. Shellard; M. Claire Walker; Richard D. H. Whelan; John ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 632 KB

Two sublines were derived from a human bladder carcinoma continuous cell line (RTI 12-P), one by exposure to fractionated X-irradiation (RTI IZ-DXRa) and the other by continuous exposure to cisplatin (RT 112-CP). RTI I2-DXR8 cells were I .6to 2-fold more sensitive to cisplatin and 2 analogues, carbo